Synapse - Matthew Hellmann

Search Within

Matthew David Hellmann

Results (60)

Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancer

Journal Article

Castellanos, S. H.; Pagano, A.; Plodkowski, A. J.; Girshman, J.; Hellmann, M. D.; Rizvi, H.; Flynn, J.; Zheng, J.; Capanu, M.; Halpenny, D. F.; more...
Lung Cancer (2021)

Fulltext@MSK | Save

Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity

Journal Article

Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
Cancer Cell (2021)

Fulltext@MSK | Save

Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer

Journal Article

Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade

Journal Article

Beattie, J.; Rizvi, H.; Fuentes, P.; Luo, J.; Schoenfeld, A.; Lin, I. H.; Postow, M.; Callahan, M.; Voss, M. H.; Shah, N. J.; more...
Journal for ImmunoTherapy of Cancer (2021)

Fulltext@MSK | Save

Locoregional control, failure patterns and clinical outcomes in patients with stage III non-small cell lung cancers treated with chemoradiation and durvalumab

Meeting Abstract

Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A.; Simone, C. B.; Gelblum, D. Y.; Wu, A. J. C.; Lee, N. Y.; Kris, M. G.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine

Meeting Abstract

Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer

Journal Article

Schoenfeld, A.; Bandlamudi, C.; Lavery, J. A.; Montecalvo, J.; Namakydoust, A.; Rizvi, H.; Egger, J.; Concepcion, C. P.; Paul, S.; Arcila, M. E.; more...
Clinical Cancer Research (2020)

Fulltext@MSK | Save

One-year disease outcomes in stage III non-small cell lung cancers treated with trimodality therapy vs concurrent chemoradiation and durvalumab

Meeting Abstract

Shaverdian, N.; Shepherd, A. F.; Offin, M.; Lobaugh, S.; Zhang, Z.; Simone, C. B. 2nd; Gelblum, D.; Wu, A. J.; Kris, M. G.; Rudin, C. M.; more...
International Journal of Radiation Oncology, Biology, Physics (2020)

Fulltext@MSK | Save

Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer

Meeting Abstract

Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Overcoming immune resistance with rationally designed combination immunotherapy

Meeting Abstract

Zappasodi, R.; Budhu, S.; Sirard, C.; Qi, J.; Liu, C.; Li, Y.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Zhong, H.; more...
Cancer Research (2020)

Fulltext@MSK | Save